|
|
Article: Stiefel Laboratories and Grupo Uriach Enter Licensing Agreement for Innovative Molecule.
- Article from:
- PR Newswire
- Article date:
- September 21, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Investigational Agent, UR-9825 (albaconazole), a broad-spectrum antifungal, for oral and topical administration in dermatology and other indications
Deal is largest in Stiefel's history, Potential for billion dollars in sales
CORAL GABLES, Fla., and BARCELONA, Spain, Sept. 21 /PRNewswire/ -- Stiefel Laboratories, the world's largest privately held company specializing in dermatology and Grupo Uriach, a Spanish pharmaceutical company focused on drug discovery and early drug development, announced today that they have entered into a licensing agreement to develop and market a new chemical entity, UR- 9825 (albaconazole), an oral broad spectrum antifungal ...